BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24830805)

  • 21. 'Very difficult for an ordinary guy': Factors influencing the quality of treatment decision-making amongst men diagnosed with localised and locally advanced prostate cancer: Findings from a UK-wide mixed methods study.
    Wagland R; Nayoan J; Matheson L; Rivas C; Brett J; Downing A; Wilding S; Butcher H; Gavin A; Glaser AW; Watson E
    Patient Educ Couns; 2019 Apr; 102(4):797-803. PubMed ID: 30527732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is "Active Surveillance" an Acceptable Alternative?: A Qualitative Study of Couples' Decision Making about Early-Stage, Localized Prostate Cancer.
    Le YL; McFall SL; Byrd TL; Volk RJ; Cantor SB; Kuban DA; Mullen PD
    Narrat Inq Bioeth; 2016; 6(1):51-61. PubMed ID: 27346824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners.
    Schofield P; Gough K; Hyatt A; White A; Frydenberg M; Chambers S; Gordon LG; Gardiner R; Murphy DG; Cavedon L; Richards N; Murphy B; Quinn S; Juraskova I
    Trials; 2021 Jan; 22(1):49. PubMed ID: 33430950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of family ties on men's prostate cancer screening, biopsy, and treatment decisions.
    Shaw EK; Scott JG; Ferrante JM
    Am J Mens Health; 2013 Nov; 7(6):461-71. PubMed ID: 23459024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
    Mader EM; Li HH; Lyons KD; Morley CP; Formica MK; Perrapato SD; Irwin BH; Seigne JD; Hyams ES; Mosher T; Hegel MT; Stewart TM
    BMC Urol; 2017 May; 17(1):35. PubMed ID: 28482875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer.
    Zeliadt SB; Penson DF; Moinpour CM; Blough DK; Fedorenko CR; Hall IJ; Smith JL; Ekwueme DU; Thompson IM; Keane TE; Ramsey SD
    BJU Int; 2011 Sep; 108(6):851-6; discussion 856-7. PubMed ID: 21244609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.
    Volk RJ; Kinsman GT; Le YC; Swank P; Blumenthal-Barby J; McFall SL; Byrd TL; Mullen PD; Cantor SB
    J Health Commun; 2015; 20(9):1014-20. PubMed ID: 26066011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partner's influence on patient preference for treatment in early prostate cancer.
    Srirangam SJ; Pearson E; Grose C; Brown SC; Collins GN; O'Reilly PH
    BJU Int; 2003 Sep; 92(4):365-9. PubMed ID: 12930420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The experiences of unpartnered men with prostate cancer: a qualitative analysis.
    Kazer MW; Harden J; Burke M; Sanda MG; Hardy J; Bailey DE;
    J Cancer Surviv; 2011 Jun; 5(2):132-41. PubMed ID: 21113818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire.
    Devos J; Van Praet C; Decaestecker K; Claeys T; Fonteyne V; Decalf V; De Meerleer G; Ost P; Lumen N
    Acta Clin Belg; 2015 Aug; 70(4):272-9. PubMed ID: 25816107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Qualitative Study of Men's Experiences Using Navigate: A Localized Prostate Cancer Treatment Decision Aid.
    Todio E; Schofield P; Sharp J
    MDM Policy Pract; 2023; 8(2):23814683231198003. PubMed ID: 37719768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer.
    Smith AB; Mancuso P; Sidhom M; Wong K; Berry M; Rincones O; Forstner D; Bokey L; Girgis A
    BMJ Open; 2017 Nov; 7(11):e018403. PubMed ID: 29102996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. To tell or not to tell: patterns of disclosure among men with prostate cancer.
    Gray RE; Fitch M; Phillips C; Labrecque M; Fergus K
    Psychooncology; 2000; 9(4):273-82. PubMed ID: 10960925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What Is a "Good" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer.
    Orom H; Biddle C; Underwood W; Nelson CJ; Homish DL
    Med Decis Making; 2016 Aug; 36(6):714-25. PubMed ID: 26957566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding Advanced Prostate Cancer Decision Making Utilizing an Interactive Decision Aid.
    Jones RA; Hollen PJ; Wenzel J; Weiss G; Song D; Sims T; Petroni G
    Cancer Nurs; 2018; 41(1):2-10. PubMed ID: 27811543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of the use of alternative therapies by men with localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
    Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
    Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ; Breckon E
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.